P Tyagi, P Sharma, BC Sharma… - European journal of …, 2011 - journals.lww.com Materials and methods: One hundred and seventy-six consecutive patients with cirrhosis and ascites were screened. Patients with creatinine clearance (Ccl) between 41 and 80 ml/min and serum creatinine of less than 1.5 mg/dl in absence of renal disease were randomized to ... Related articles - All 5 versions
V Arroyo… - 2011 - content.karger.com Abstract: A major event of cirrhosis is the development of a progressive deterioration of circulatory function due to splanchnic arterial vasodilation and impairment in cardiac function. This feature determines a homeostatic activation of the renin-angiotensin-aldosterone system, ... Related articles
JM Hutchinson… - Gut, 2011 - gut.bmj.com We have read the comprehensive review article by Cárdenas and Ginès that details the management of ascites, hyponatraemia, hepatorenal syndrome, bacterial infections, hepatic encephalopathy and variceal bleeding in patients with decompensated chronic liver disease.1 It is well ... Cited by 1 - Related articles - All 2 versions
A Cardenas… - Gut, 2011 - gut.bmj.com We thank Dr Hutchinson and Dr Davies for their comments1 regarding the use of alter- native options in patients with cirrhosis and refractory ascites. The use of other potential therapies for patients with refractory ascites is attractive and should perhaps be consid- ered in ... Related articles
F Wong, H Watson, A Gerbes, H Vilstrup… - Gut, 2011 - gut.bmj.com Results Satavaptan was not more effective than placebo in the control of ascites in any of the populations studied as estimated by the primary efficacy endpoints: worsening of ascites (study 1) and the cumulative number of large-volume paracenteses during 12 weeks (studies 2 ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
